The economic inpact of nosocomial infection on hospital management

医院感染对医院管理的经济影响

基本信息

  • 批准号:
    08672709
  • 负责人:
  • 金额:
    $ 1.09万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1998
  • 项目状态:
    已结题

项目摘要

In order to clarify the economic impact of nosocomial infection on hospital management, we studied the cost of MRSA testing and treatment, and concomitantly the costs necessary to cover methicillin-resistant Staphylococcus aureus (MRSA) infection control in general hospital (114beds).The subjects of the study were 15 patients infected with MRSA during the hospital stay and several members of the nursing staff charged with their care. Examination of the background of the 15 patients showed that they were elderly, ranging in age from 60 to 94 years (mean age ; 79 years), and that they were bedfast with diabetes mellitus, cerebrovascular disease, or heart disease, etc. In addition, most of them had been admited for treatment of pneumonia, and developed MRSA pneumonia as a complication.Total cost for MRSA infection control was calculated from the sum of expendable suppulies per patient per day, from a nurse's wages per patient per day, and from the average duration in days of a patient's s … More tay in an isolation room.The sum of expendable supplies, including extra charge for an isolation room, was 19,070 yen per patient per day, and the nurse's wages 2,214 yen per patient per day. The average isolation period was 75 days, such that the total cost for MRSA infection control was calculated to be 1.6 million yen per patient. Since there were 46 new cases of MRSA infection during the year, the total cost for the year was 73 million yen.The cost of the testing and treatment for MRSA infection was 1.3 million yen per patient, making the total cost for the year was 60 million yen.Based on the above findings, it was learned that many costs which do not appear in the clinical care fees are needed in the management of MRSA infected patients. It was also exhibited thath the ordinary private room charge is not obtained because of isolation, and that this has a great impact on hospital management. In the future we would like to assess measures for preventing MRSA infection in elderly pneumonia patients. Less
为了明确医院感染对医院管理的经济影响,我们研究了MRSA检测和治疗的费用,以及综合医院(114个床位)耐甲氧西林金黄色葡萄球菌(MRSA)感染控制所需的费用。研究对象是15名住院期间感染MRSA的患者和几名负责护理的护理人员。对这15名患者的背景检查显示,他们均为老年人,年龄在60岁至94岁之间(平均年龄79岁),患有糖尿病、脑血管疾病或心脏病等卧床不起。此外,他们中的大多数人因肺炎入院治疗,并出现了MRSA肺炎并发症。控制MRSA感染的总费用是根据以下总和计算的: 每个病人每天的消耗品,来自每个病人每天护士的工资,以及病人在隔离室的平均停留天数。消耗品的总和,包括隔离室的额外费用,是每个病人每天 19,070 日元,护士的工资是每个病人每天 2,214 日元。平均隔离期为75天,因此计算出每名患者控制MRSA感染的总成本为160万日元。由于年内新增 MRSA 感染病例 46 例,全年总费用为 7300 万日元。MRSA 感染的检查和治疗费用为每名患者 130 万日元,全年总费用为 6000 万日元。根据上述调查结果,了解到在 MRSA 感染患者的管理中需要许多临床护理费用中没有出现的费用。还显示,普通包间费用因隔离而无法获得,这对医院管理造成很大影响。未来我们希望评估预防老年肺炎患者 MRSA 感染的措施。较少的

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Michiko Takamine et al: "The Study of the working hours and expenses necessary to cover nosocomial infection prevention"Journa of Japan Academy of Nursing Science. 17(3). 300-301 (1997)
高峰美智子等:“预防医院感染所需的工作时间和费用的研究”日本护理学会杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Michiko Takamine: "INCIDENCE OF NOSOCOMIAL INFECTION 6N HOSPITAL MANAGEMENT"International Nursing Research Conference. 3. 273 (1998)
Michiko Takamine:“院内感染发生率 6N 医院管理”国际护理研究会议。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
高峰道子: "院内感染防止に要する経済的負担と労働時間の実態調査"日本看護科学学会誌. 17. 300-301 (1997)
高峰道子:“预防医院感染所需的经济负担和工作时间的调查”日本护理学会杂志 17. 300-301 (1997)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Michiko Takamine et al: "INCIDENCE OF NOSOCOMIAL INFECTION ON HOSPITAL MANAGEMENT"International Nursing Research Conference. 3. 273 (1998)
Michiko Takamine 等人:“院内感染对医院管理的影响”国际护理研究会议。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TANAKA Michiko其他文献

TANAKA Michiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TANAKA Michiko', 18)}}的其他基金

analysis of pathogeny of Herpes simplex virus 1 using original methods of recombination for virus genome
独创病毒基因组重组方法分析单纯疱疹病毒1型病原
  • 批准号:
    23790511
  • 财政年份:
    2011
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Respiratory rehabilitation in the elderly patient with COPD who aimed the palliative intervention of dyspnea.
以呼吸困难姑息干预为目标的老年慢性阻塞性肺病患者的呼吸康复。
  • 批准号:
    20592685
  • 财政年份:
    2008
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of the regulatory proteins of HSV using the mutagenesis in E. coli
利用大肠杆菌诱变分析 HSV 的调节蛋白
  • 批准号:
    20790361
  • 财政年份:
    2008
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Factor Analysis of Prolonged Hospital Stay of Elderly Patients with Community-Acquired Pneumonia
老年社区获得性肺炎患者住院时间延长的因素分析
  • 批准号:
    14572222
  • 财政年份:
    2002
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Genomic Epidemiology of Methicillin-Resistant Staphylococcus aureus Infections Prior to and During the COVID-19 Pandemic
COVID-19 大流行之前和期间耐甲氧西林金黄色葡萄球菌感染的基因组流行病学
  • 批准号:
    494305
  • 财政年份:
    2023
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Operating Grants
Transfer and stability of antimicrobial resistance (AMR) genes in Methicillin-Resistant Staphylococcus aureus (MRSA)
耐甲氧西林金黄色葡萄球菌 (MRSA) 中抗菌素耐药性 (AMR) 基因的转移和稳定性
  • 批准号:
    2734850
  • 财政年份:
    2022
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Studentship
Combating Fosfomycin Resistance in Methicillin-Resistant Staphylococcus aureus
对抗耐甲氧西林金黄色葡萄球菌中的磷霉素耐药性
  • 批准号:
    10580471
  • 财政年份:
    2022
  • 资助金额:
    $ 1.09万
  • 项目类别:
Rapid detection of Methicillin-resistant Staphylococcus aureus outbreaks using a multi-omics approach
使用多组学方法快速检测耐甲氧西林金黄色葡萄球菌爆发
  • 批准号:
    466548
  • 财政年份:
    2021
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Studentship Programs
Vancomycin dosing for severe methicillin-resistant Staphylococcus aureus infections: a pilot study
万古霉素治疗严重耐甲氧西林金黄色葡萄球菌感染的剂量:一项初步研究
  • 批准号:
    466572
  • 财政年份:
    2021
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Studentship Programs
Uncovering new targets for the fight against methicillin resistant Staphylococcus aureus infections: Targeting Polyamine Detoxification
发现对抗甲氧西林耐药金黄色葡萄球菌感染的新靶点:针对多胺解毒
  • 批准号:
    466833
  • 财政年份:
    2021
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Studentship Programs
The S. aureus Network Adaptive Platform Trial (SNAP) Canada: A Randomized Controlled Trial for Penicillin-susceptible, Methicillin-susceptible, and Methicillin-resistant Staphylococcus aureus Bloodstream Infections in Hospitalized Patients
加拿大金黄色葡萄球菌网络适应性平台试验 (SNAP):针对住院患者青霉素敏感、甲氧西林敏感和甲氧西林耐药金黄色葡萄球菌血流感染的随机对照试验
  • 批准号:
    433304
  • 财政年份:
    2020
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Operating Grants
Rapid, reagent-free technology for identification of methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) in clinical microbiology labs
在临床微生物学实验室中快速、免试剂鉴定耐甲氧西林金黄色葡萄球菌 (MRSA) 和耐万古霉素肠球菌 (VRE)
  • 批准号:
    500176-2016
  • 财政年份:
    2019
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Idea to Innovation
The making of a Superbug. Understanding the mechanisms of high level antibiotic resistance in Methicillin Resistant Staphylococcus aureus (MRSA)
超级细菌的形成。
  • 批准号:
    2289038
  • 财政年份:
    2019
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Studentship
Development of Multispecific Antibodies for the treatment of Methicillin Resistant Staphylococcus ‎aureus (MRSA) infection
开发治疗耐甲氧西林金黄色葡萄球菌 (MRSA) 感染的多特异性抗体
  • 批准号:
    9866170
  • 财政年份:
    2017
  • 资助金额:
    $ 1.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了